About 5 200 reports

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

By Firstword Pharma

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend.Indeed, the chronic heart failure agent is believed to...

516 645 449
Sep 3014

CNS Drug News 16 FEBRUARY 2015

20 pages • By Espicom Business Intelligence

Industry Trend Analysis - Abuse-Deterrent Opioid Market Seeing High ActivityIndustry Trend Analysis - Neupro's Expansion Into China Will Boost UCB's RevenuesIndustry Brief - Teva UK Launches MemantineIndustry Brief - AB Science Reports Successful Completion Of Futility Test For Masitinib In ADIndustry Brief - Regulus Earns...

825 1 114 685
Feb 2015

Poland Pharmaceuticals and Healthcare Report Q2 2015

110 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Polish pharmaceutical market is heavily dependent on public healthcare spending; any negative economic developments will have an impact on the market in the short term. Over the past five years, Poland's economic outperformance has been vital to maintaining positive...

985 1 300 818
Feb 2015

Japan Pharmaceuticals and Healthcare Report Q2 2015

156 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Japan's healthcare system will come under increasing financial strain due to the ageing population and the high use of patented medicines. This provides an impetus for the government to use cost containment measures including policies to encourage the uptake of generic...

985 1 300 818
Feb 2015

Peru Pharmaceuticals and Healthcare Report Q2 2015

114 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Longstanding trade agreements with the US and EU, along with efficient regulations for quality control will continue to make Peru an appealing destination for drugmakers. However, while the pharmaceutical and healthcare markets continue to grow, the national economy continues...

985 1 300 818
Feb 2015

Hong Kong Pharmaceuticals and Healthcare Report Q2 2015

118 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: The Hong Kong government will continue to shift healthcare provision towards the private sector due to the growing financial strain and an overburdened public healthcare system. While this could create cost barriers to medicines, we highlight that the strong earning power...

985 1 300 818
Feb 2015

Argentina Pharmaceuticals and Healthcare Report Q2 2015

138 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: Despite economic activity forecast to continue to decline over the medium-term, Argentina's gradual transition towards more pragmatic and market-friendly economic policies will likely benefit key economic sectors in the long-term, including the pharmaceutical industry....

985 1 300 818
Feb 2015

Germany Pharmaceuticals and Healthcare Report Q2 2015

111 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: One of the largest markets in Europe, Germany will continue to experience rising demand for pharmaceuticals, sustained by an ageing population with a strong bias towards patented medicines. In spite of this, additional restrictions on reimbursement, tempered by government's...

985 1 300 818
Feb 2015

Drug Delivery Insight 16 FEBRUARY 2015

20 pages • By Espicom Business Intelligence

Industry Trend Analysis - AstraZeneca Further Bolsters Respiratory PortfolioIndustry Trend Analysis - Acquisition Of Hospira Gives Pfizer Entrance To Biosimilar And Medical Device MarketsIndustry Brief - Theravance/Mylan Collaboration For COPDIndustry Brief - Vectura's Chief Executive To Step DownIndustry Brief - Matinas Acquires...

825 1 114 685
Feb 2015

Cancer Drug News 16 FEBRUARY 2015

16 pages • By Espicom Business Intelligence

Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology PortfolioIndustry Brief - Kinex Licenses BCRP-Targeted Patents From Hong Kong Polytechnic University/McGill UniversityIndustry Brief - Lion Obtains Licence From NIH To Develop TIL Therapy In MMIndustry Trend Analysis - Takeda Can Replicate...

825 1 114 685
Feb 2015

Bulgaria Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: In 2015, we expect the fallout from the banking and NHIF funding crises to impact pharmaceutical and healthcare spending, but given the passage of reforms to healthcare financing, we hold a more positive view for the long term development of the pharmaceutical & healthcare...

985 1 300 818
Feb 2015

Cystic Fibrosis Market in Europe 2015-2019

113 pages • By Infiniti Research Limited

About Cystic FibrosisCystic fibrosis, also known as mucoviscidosis, is a genetically inherited disease. The primary symptoms of cystic fibrosis include high salt content in the sweat, breathing difficulties, secretion of abnormally viscous mucus, respiratory complications, difficulties related to digestion, and growth anomalies. Cystic...

2 400 3 000 1 920
Feb 2015

Global Preventable Vaccines Market 2015-2019

137 pages • By Infiniti Research Limited

About Preventable VaccinesVaccines can be defined as a product that stimulates a person’s immune system to produce immunity to a specific disease, thereby protecting the person from that disease. According to the CDC, vaccines are usually administered through needle injections, but can also be administered orally or sprayed into the nose....

2 400 3 000 1 920
Feb 2015

2015 Strategies in the German Hospital Microbiology Testing Market

897 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 897 pages, 74 tables, and presents a comprehensive opportunities in the German hospital microbiology testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Strategies in the Japanese Hospital Microbiology Testing Market

891 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive opportunities in the Japanese hospital microbiology testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 800 3 500 2 240
Feb 2015

2015 Strategies in the US Hospital Microbiology Testing Market

997 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 997 pages, 87 tables, and presents a comprehensive opportunities in the US hospital microbiology testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends...

3 520 4 400 2 816
Feb 2015

2015 Strategies in the French Hospital Microbiology Testing Market

897 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive opportunities in the French hospital microbiology testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Strategies in the Spanish Hospital Microbiology Testing Market

880 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 880 pages, 73 tables, and presents a comprehensive opportunities in the Spanish hospital microbiology testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Opportunities in the US Hospital Infectious Disease Testing Market

997 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including: Major issues pertaining to the US hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

3 520 4 400 2 816
Feb 2015

2015 Opportunities in the Italian Hospital Infectious Disease Testing Market

887 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 887 pages, 72 tables, and presents a comprehensive analysis of the Italian hospital infectious disease testing market, including:  Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Strategies in the Italian Hospital Microbiology Testing Market

887 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 887 pages, 72 tables, and presents a comprehensive opportunities in the Italian microbiology disease testing market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Strategies in the UK Hospital Microbiology Testing Market

886 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 886 pages, 67 tables, and presents a comprehensive opportunities in the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Opportunities in the Spanish Hospital Infectious Disease Testing Market

880 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 880 pages, 73 tables, and presents a comprehensive analysis of the Spanish hospital infectious disease testing market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Opportunities in the German Hospital Infectious Disease Testing Market

897 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Opportunities in the French Hospital Infectious Disease Testing Market

897 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 897 pages, 77 tables, and presents a comprehensive analysis of the French hospital infectious disease testing market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

2015 Opportunities in the Japanese Hospital Infectious Disease Testing Market

891 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 891 pages, 75 tables, and presents a comprehensive analysis of the Japanese hospital infectious disease testing market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

3 040 3 800 2 432
Feb 2015

2015 Opportunities in the UK Hospital Infectious Disease Testing Market

886 pages • By Venture Planning Group

This new report from VPGMarketResearch.com contains 886 pages, 67 tables, and presents a comprehensive analysis of the UK hospital infectious disease testing market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological...

2 320 2 900 1 856
Feb 2015

Moderate to Severe Pain: Novel Abuse Deterrent Formulation Technologies and Emergence of Novel Mechanisms in the Management of Pain

65 pages • By MP Advisors

Pain is the leading cause of disability in the US, affecting more than cancer, diabetes and heart disease combined. Current analgesics for persistent pain are relatively ineffective, are associated with significant adverse effects or abuse liability, and do not reduce pain in all treated individuals. Opioids (e.g., morphine, codeine, oxycodone)...

2 400 3 000 1 920
Feb 2015

Generic Drugs Market in Japan 2015-2019

94 pages • By Infiniti Research Limited

About Generic DrugsA generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs...

2 000 2 500 1 600
Feb 2015

Czech Republic Pharmaceuticals and Healthcare Report Q2 2015

104 pages • By Business Monitor International

Includes 3 FREE quarterly updatesBMI View: With recently implemented cost-saving measures, legislative changes, and health insurance reforms, the Czech Republic is set to recover from its recent period of stagnancy and decline. Indeed, these changes will help to provide for the growing demand for innovative drugs...

985 1 300 818
Feb 2015